Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
INFORMATION MOUNJARO 7.5mg KwikPen is a single-patient-use, multi-dose pre-filled pen containing tirzepatide a synthetic dual GIP/GLP-1 receptor agonist developed by Eli Lilly and Company Limited at a strength of 7.5mg per 0.6ml dose.[3][4] In the U.S., MOUNJARO (tirzepatide) is indicated for type 2 diabetes in adults and pediatric patients aged 10 years and older
Before stopping treatment, discussion with a qualified healthcare provider is essential to assess individual readiness, confirm that lifestyle changes are in place, and establish a plan for managing weight regain or metabolic changes
A medical provider will review your history and help determine if injections are safe for you
Create a consistent injection routine by setting weekly reminders and preparing your injection site in advance
Some of these side effects might influence a persons risk of developing anemia
US$ 25.48
US$ 23.89
US$ 29.47
US$ 27.36
US$ 29.68
